London, April 07, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of "Peptide Therapeutics: Contract API Manufacturing Market (2nd Edition), 2022-2035" report to its list of ...

INTRODUCTION Over the years, the popularity of biologics has led to an evident shift in the focus of pharmaceutical companies, from traditional interventions towards more complex and advanced ...

Industry experts share their views on the outsourcing model and the current and future direction of contract chemical API manufacturing. As fine-chemical companies, contract manufacturers, and ...

The global high potency API contract manufacturing market, valued at USD 8 billion in 2022, is poised for robust growth, with projections to reach USD 16 billion by 2032. This remarkable expansion, ...

Recipharm is pleased to announce that it has signed an agreement with Daewoong, the leading Korean based pharmaceutical company with a strong presence in respiratory therapeutics, for a ten year ...

XMax (XMAX) announced a major commercial milestone in its artificial intelligence rollout, securing multiple enterprise AI model API service agreements with a combined potential value of up to $25 ...

BOSTON--(BUSINESS WIRE)--LinkSquares, the company behind the AI-powered contract management platform of choice, today announced the launch of LinkSquares API, which encompasses all API offerings ...